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ABSTRACT 
 
 Bronchial asthma (BA) and obesity due to their high prevalence and medical and social significance belong 
to global problems of healthcare. Obesity effect on asthma development includes the following mechanisms: impact on 
respiratory function, inflammation and common genetic factors. The aim of our research was to study the association 
between BMI and Gln27Glu polymorphism in the ADRB2 gene in BA patients. Patients with bronchial asthma were divided 
into 3 groups depending on their BMI: Group I – 110 patients with normal body mass; group II – 26 overweight patients, 
group III – 59 obese patients. Gln27Glu polymorphism in the ADRB2 gene was detected using polymerase chain reaction. 
Statistical analysis was performed using SPSS–21 program. P-value <0.05 was considered significant. Obtained results 
showed that obesity occurred more often in Glu27Glu genotype carriers, while normal body mass was more characteristic 
of Gln27Gln genotype carriers (р = 0.001). Distribution of BMI with regard to Gln27Glu polymorphism in the ADRB2 gene in 
BA patients did not depend on gender (р=0.1). Thus, BA patients with Glu27Glu genotype of the ADRB2 gene had obesity 
significantly more often.  
Keywords: bronchial asthma, obesity, β2-adrenoceptor, Gln27Glu polymorphism. 
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INTRODUCTION 
 
Bronchial asthma (BA) and obesity due to their high prevalence and medical and social significance 
belong to global problems of healthcare. Analysis of population-based studies of body mass index (BMI) in the 
world [6, 20] allowed not only tracing the increase of number of obese people and asserting "obesity 
epidemic", but also creating on this basis a ranking of countries with the highest obesity prevalence, among 
which Mexico (32.8%) and the USA (31.8 %) ranked first [7]. BA is of equal significance as concerns its 
prevalence. Epidemiological study of asthma revealed a tendency to rapid increase in the disease incidence. 
According to the Bulletin of the World Health Organization [3], the countries with the highest prevalence of 
asthma are Great Britain – 18.4% and New Zealand – 15.1%. 
 
BA morbidity level has lately increased among obese adult population, especially among women. 
Obesity is a factor that contributes to asthma development and worsens disease control, which is confirmed 
by changes in quality of life, limitations in daily activities, severity of apnea and wheezing, frequency of rescue 
medication use, increase in  unscheduled doctor visits, ambulance calls and hospitalizations for exacerbations 
[7, 21, 22]. 
 
Obesity increases the risk of asthma and is a risk factor for persistence and asthma symptoms severity 
in children and adults [4, 5, 11]. Obesity effect on asthma includes the following mechanisms: respiratory 
function changes, inflammation and common genetic factors [2, 18, 19], in particular pleiotropic effect that is 
typical for polymorphisms in the β2-adrenergic receptor (ADRB2) genes and glucocorticosteroid (GC) receptor 
genes, which are located on chromosome 5q23-34 and are responsible for airways tone, sympathetic nervous 
system activity, and modulation of inflammation both in BA and obesity [1, 9, 13]. 
 
ADRB2 is known to be one of the main lipolytic receptors in human adipose cells; genetic variation of 
the receptor gene is associated with obesity development, energy expenditure and lipolytic function of 
adipose tissue [9, 10, 15, 17].  
 
 Thus, the aim of our research was to study the association between BMI and Gln27Glu polymorphism 
in the ADRB2 gene in BA patients.  
 
MATERIALS AND METHODS 
 
We examined 195 patients with BA – 129 men and 66 women – aged 21-71, who were undergoing 
hospital treatment at the pulmonary department at MI of Sumy Regional Council “Sumy Regional Clinical 
Hospital”.  
 
Patients with bronchial asthma were divided into 3 groups depending on their BMI. Group I comprised 
110 patients with normal body mass; group II – 26 overweight patients, group III – 59 obese patients. BA was 
diagnosed in accordance with the GINA guidelines (2016) and the Decrees of the Ministry of Health of Ukraine 
№128 issued on 19-Mar-2007 and № 868 issued on 08-Oct-2013.  BMI was assessed according to WHO criteria 
(1999). 
 
The control group consisted of 95 apparently healthy individuals with no allergies and no history of 
atopic diseases. 
 
Gln27Glu (rs1042714) polymorphism in the ADRB2 gene was detected using polymerase chain 
reaction with subsequent analysis of restriction fragment length polymorphism by means of separation with 
agarose gel electrophoresis. Statistical analysis was performed using SPSS–21 program. Significance of 
differences between the control group and BA patients was estimated by Pearson's chi-squared test (the value 
of p<0.05 was considered statistically significant).  The data were statistically processed using nonparametric 
statistical techniques, because Gaussian distribution of BMI parameters was far from normal. BMI was 
expressed through the median and interquartile range (25-th and 75-th percentiles). Obtained values of BMI 
were compared by means of rank analysis of variance (ANOVA) by Kruskal-Wallis. With this method we 
checked the null hypothesis of no difference among groups. With p>0.05, the null hypothesis of no difference 
in median values of groups was confirmed, that is groups did not differ. With p<0.05, the null hypothesis was 
not confirmed and, respectively, the alternative hypothesis was accepted stating that there were differences in 
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median values of groups. In this case, we performed pair-wise comparison of groups using Mann-Whitney 
nonparametric test. To evaluate the influence of polymorphism genotypes on obesity risk in BA patients, the 
odds ratio (OR) and 95% confidence interval (CI) were calculated. 
 
RESULTS 
 
Genotype distribution of Gln27Glu polymorphism in the ADRB2 gene with regard to BMI in BA patients 
and the control group is presented in Table 1 and Table 2. Obtained results showed that obesity occurred more 
often in the  BA patients who were Glu27Glu genotype carriers (р = 0.001 by Pearson's chi-squared test), while 
in the control group there was no significant difference, that is, genotypes had equal frequency for different 
BMI values (р = 0.9 by Pearson's chi-squared test). 
 
Table 1: Genotypes distribution of Gln27Glu polymorphism in the β2-adrenoceptor gene in dependence on 
body mass index in the control group 
 
 Control group 
BMI 
 
 
Genotypes 
Normal  
body mass 
Overweight  
n % n % 
Gln27Gln 28 75.7 9 24.3 
Gln27Glu 29 76.3 9 23.7 
Glu27Glu 16 80.0 4 20.0 
 χ2  = 3.4; р = 0.9 
 
Table 2: Genotypes distribution of Gln27Glu polymorphism in the β2-adrenoceptor gene in dependence on 
body mass index in the patients with bronchial asthma 
 
 BA patients 
BMI 
 
 
Genotypes 
Normal  
body mass 
Overweight  Obesity  
n % n % n % 
Gln27Gln 74 71.2 18 17.3 12 11.5 
Gln27Glu 34 49.3 4 5.8 31 44.9 
Glu27Glu 2 9.1 4 18.2 16 72.7 
 χ2  = 22.8; р = 0.001 
 
Performed analysis of association between BMI and Gln27Glu polymorphism in the ADRB2 gene in BA 
patients is presented in Table 3. 
 
Table 3: The median (interquartile range) of body mass index in patients with bronchial asthma with regard to 
Gln27Glu polymorphism in the ADRB2 gene  
 
         Values 
 
Genotypes 
BMI, 
kg/m2 
Gln27Gln (n=110) 24.8 (23.8 – 25.8) 
Gln27Glu (n=26) 28.9 (27.2 – 30.7) 
Glu27Glu (n=59) 32.6 (30.9 – 34.3) 
 
The results of analysis demonstrated a statistically significant difference in BMI with regard to 
Gln27Glu polymorphism in the ADRB2 gene (р=0.001 by Kruskal-Wallis). 
 
The next step included pair-wise comparison of groups using Mann-Whitney test. As comparing BMI 
values in carriers of Gln27Gln vs. Gln27Glu genotypes, as well as in carriers of Gln27Glu vs. Glu27Glu 
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genotypes, a statistically significant difference was established (р1 < 0.001 and р2 < 0.001). That is, the patients 
with Glu27Glu genotype had higher BMI values than the patients with Gln27Gln and Gln27Glu genotypes. 
 
Analysis of BMI values with regard to the genotype of the Gln27Glu polymorphism in the ADRB2 gene 
in patients of different sex demonstrated that in men there was a statistically significant difference in BMI with 
regard to Gln27Gln, Gln27Glu and Glu27Glu genotypes in the ADRB2 gene (р=0.001 by Kruskal-Wallis) (Fig.2). 
Thus, higher values of BMI were observed in men with BA and Glu27Glu genotype of the ADRB2 gene as 
compared with male carriers of Gln27Gln and Gln27Glu genotypes (р1=0.001 and р2=0.005 by Mann-Whitney); 
though, there was no significant difference in BMI between male carriers of Gln27Glu vs Glu27Glu genotypes 
(р3=0.1 by Mann-Whitney). In women there also was a statistically significant difference in BMI (р=0.001 by 
Kruskal-Wallis) (Fig. 3). Female patients with BA and Glu27Glu genotype of the ADRB2 gene  had higher BMI 
values as compared with those having Gln27Gln and Gln27Glu genotypes of Gln27Glu polymorphism in the 
ADRB2 gene (p=0.001 by Mann-Whitney). 
 
                                 
 
Figure 2. The median (interquartile range) of BMI 
values in men 
 
Figure 3. The median (interquartile range) of BMI 
values in women 
DISCUSSION 
 
According to the data of epidemiological studies performed among adults with BA, obesity was found 
to precede bronchial asthma and double asthma risk in men and women (OR = 1.92, CI − 95% 1.43 − 2.59, p 
<0.0001) [2].  
 
Meta-analysis of 18 studies demonstrated association of Gln27Glu polymorphism with obesity risk in 
heterozygous model (Gln/Glu vs Gln/Gln: OR = 1.16; CI − 95% 1.04 – 1.30, р = 0.009) and dominant model 
(Gln/Glu + Glu/Glu vs Gln/Gln: OR = 1.2; CI − 95% 1.00 – 1.44, р = 0.04) [23].   Ishiyama-Shigemoto S. et al 
(1999) in their study also stated that frequency of Glu27Glu genotype was two times higher in obese patients 
as compared with the control group (р= 0.001) [9]. In our study we documented higher frequency of Glu27Glu 
genotype in obese patients as compared with Gln27Gln and Gln27Glu genotypes (р = 0.001). These studies 
show that Gln27Glu polymorphism in the ADRB2 gene is involved into obesity pathogenesis. 
 
Leite N. et al. (2015) proved that Glu27 allele was observed more often in overweight patients with BA 
as compared with those having normal body mass (р = 0.03) [14]. Still, other studies demonstrated association 
of obesity with Gln/Gln genotype of Gln27Glu polymorphism in the ADRB2 gene. Thus, Maha H. et al. (2008) 
established that the frequency of Gln/Gln homozygotes was higher among obese patients, who had higher 
concentration of triglycerides, leptin and insulin, as compared with Gln/Glu heterozygotes and the minor allele 
(Glu/Glu) homozygotes [15]. Unlike the above-mentioned study, B. Kortner and A. Wolf when determining the 
frequency of Gln27Glu polymorphism in the ADRB2 gene in patients with morbid obesity vs the control group 
showed that the frequency of Glu/Glu genotype was almost identical in both groups (0.41 and 0.43, 
respectively; p = 0.68). The researchers found no evidence of association between Gln27Glu polymorphism in 
the ADRB2 gene and development of morbid obesity [12]. 
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Large V. et al. (1997) documented an association between Gln27Glu polymorphism in the ADRB2 gene 
and gender features, that is, female carriers of Glu27Glu genotype had 2.09 times higher risk of obesity (OR = 
2.09, CI – 95% 1.17 – 3.74, р=0.01) as compared with men [13]. Hellström L. and Large V. (2008) in their study 
found positive correlation between obesity and Gln27Glu polymorphism in the ADRB2 gene in women, while in 
men they observed negative correlation (p = 0.013) [8].  These data suggest that genetic factors have different 
effects on obesity development in men and women. 
 
Unlike the previous researchers, Mori Y. and Kim-Motoyama H. (2009), when studying the influence of 
Gln27Glu polymorphism in the ADRB2 gene on obesity development and subcutaneous fat distribution, 
demonstrated much higher frequency of Glu/Glu genotype in obese men as compared to obese women (р  = 
0.04) [17]. Our results concerning distribution of genotypes of Gln27Glu polymorphism in the ADRB2 gene with 
regard to BMI and gender in BA patients showed no significant differences.  
 
Thus, these study results show that obesity was observed more frequently in Glu27Glu genotype 
carriers, while normal body mass – in the carriers of Gln27Gln genotype of Gln27Glu polymorphism in the 
ADRB2 gene in BA patients, which is congruent with the data of foreign researches.  
 
CONCLUSIONS 
 
• BA patients with Glu27Glu genotype of the ADRB2 gene had obesity significantly more often as 
compared with Gln27Gln and Gln27Glu genotype carriers. 
• Distribution of genotypes of Gln27Glu polymorphism in the ADRB2 gene with regard to BMI and 
gender in BA patients showed no significant differences. 
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